ICLR ICON Public Limited Company Stock Quote

ICLR [NASD]

Healthcare | Diagnostics & Research | Ireland

Index	-	P/E	40.65	EPS (ttm)	6.83	Insider Own	4.00%	Shs Outstand	52.91M	Perf Week	4.85%
Market Cap	22.10B	Forward P/E	25.07	EPS next Y	11.07	Insider Trans	0.00%	Shs Float	51.71M	Perf Month	3.29%
Income	363.90M	PEG	3.56	EPS next Q	2.42	Inst Own	81.50%	Short Float	1.63%	Perf Quarter	29.67%
Sales	3.19B	P/S	6.92	EPS this Y	-9.40%	Inst Trans	1.10%	Short Ratio	1.45	Perf Half Y	31.68%
Book/sh	38.33	P/B	7.24	EPS next Y	20.86%	ROA	10.70%	Target Price	249.23	Perf Year	36.07%
Cash/sh	13.28	P/C	20.90	EPS next 5Y	11.43%	ROE	19.30%	52W Range	168.76 - 301.72	Perf YTD	42.36%
Dividend	-	P/FCF	44.53	EPS past 5Y	9.40%	ROI	15.60%	52W High	-8.00%	Beta	0.83
Dividend %	-	Quick Ratio	2.10	Sales past 5Y	12.20%	Gross Margin	28.40%	52W Low	64.48%	ATR	6.89
Employees	16480	Current Ratio	2.10	Sales Q/Q	40.50%	Oper. Margin	14.30%	RSI (14)	65.99	Volatility	1.79% 2.78%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	53.60%	Profit Margin	11.40%	Rel Volume	0.77	Prev Close	276.57
Shortable	Yes	LT Debt/Eq	0.17	Earnings	Jul 21 AMC	Payout	0.00%	Avg Volume	580.13K	Price	277.58
Recom	2.10	SMA20	3.20%	SMA50	7.03%	SMA200	25.04%	Volume	451,840	Change	0.37%

Sep-27-21

Upgrade

JP Morgan

Neutral → Overweight

$230 → $320

Aug-05-21

Resumed

Credit Suisse

Outperform

$250

Jul-23-21

Upgrade

Citigroup

Neutral → Buy

$260

Jul-14-21

Initiated

Citigroup

Neutral

$220

Apr-13-21

Resumed

BofA Securities

Neutral

$220

Apr-01-21

Upgrade

Wells Fargo

Equal Weight → Overweight

$200 → $235

Mar-08-21

Upgrade

Robert W. Baird

Neutral → Outperform

$215

Mar-03-21

Initiated

Barclays

Equal Weight

$200

Mar-01-21

Upgrade

UBS

Neutral → Buy

$207 → $232

Feb-26-21

Upgrade

Truist

Hold → Buy

$280

Jul-24-20

Downgrade

BofA Securities

Buy → Neutral

Apr-20-20

Downgrade

Robert W. Baird

Outperform → Neutral

$151

Mar-26-20

Upgrade

Barclays

Equal Weight → Overweight

Mar-02-20

Initiated

Deutsche Bank

Hold

Jan-27-20

Downgrade

SunTrust

Buy → Hold

$170 → $182

Jan-08-20

Initiated

Wells Fargo

Equal Weight

$180

Jan-07-20

Initiated

Citigroup

Neutral

$185

Sep-23-19

Downgrade

KeyBanc Capital Markets

Overweight → Sector Weight

Jul-26-19

Upgrade

UBS

Sell → Neutral

Jan-25-19

Upgrade

Mizuho

Neutral → Buy

Oct-15-21 08:36AM	Are Strong Financial Prospects The Force That Is Driving The Momentum In ICON Public Limited Company's NASDAQ:ICLR) Stock? Simply Wall St.
Oct-13-21 03:01PM	Icon PLC (ICLR) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
Oct-12-21 07:55PM	Hedge Funds Are Crazy About ICON Public Limited Company (ICLR) Insider Monkey
Sep-22-21 04:05PM	Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology Business Wire
Sep-19-21 10:24AM	Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now? Simply Wall St.
Sep-02-21 06:00AM	ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference Business Wire
Aug-19-21 09:27AM	Charles River (CRL) at a 52-Week High: What's Driving It? Zacks
Aug-18-21 02:24PM	Is ICON Public Limited (ICLR) A Smart Long-Term Buy? Insider Monkey
12:45PM	Icon PLC (ICLR) is an Incredible Growth Stock: 3 Reasons Why Zacks
Aug-04-21 05:38AM	What Kind Of Shareholders Hold The Majority In ICON Public Limited Company's (NASDAQ:ICLR) Shares? Simply Wall St.
Jul-30-21 09:15AM	Icon PLC (ICLR) Soars to 52-Week High, Time to Cash Out? Zacks
Jul-29-21 12:20PM	Surging Earnings Estimates Signal Upside for Icon PLC (ICLR) Stock Zacks
Jul-26-21 09:27AM	Top Ranked Growth Stocks to Buy for July 26th Zacks
09:22AM	New Strong Buy Stocks for July 26th Zacks
Jul-22-21 06:01PM	Icon PLC (ICLR) Q2 2021 Earnings Call Transcript Motley Fool
Jul-21-21 05:35PM	Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates Zacks
04:15PM	ICON Reports Second Quarter 2021 Results Business Wire
06:00AM	ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting Business Wire
Jul-19-21 12:45PM	Here is Why Growth Investors Should Buy Icon PLC (ICLR) Now Zacks
Jul-14-21 03:00PM	Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy? Zacks
08:30AM	Amedisys (AMED) Latest New York Assets Buyout Aids Home Health Zacks
Jul-09-21 02:35AM	Need To Know: Analysts Are Much More Bullish On ICON Public Limited Company (NASDAQ:ICLR) Revenues Simply Wall St.
Jul-06-21 11:37AM	Where Do Hedge Funds Stand On ICON Public Limited Company (ICLR)? Insider Monkey
Jul-02-21 12:45PM	Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think " Yes " Zacks
07:15AM	Icon PLC (ICLR) Soars 4.4%: Is Further Upside Left in the Stock? Zacks
Jul-01-21 08:43AM	ICON acquisition creates world-leading healthcare intelligence and clinical research organisation Business Wire
Jun-28-21 06:07PM	DT Midstream Set to Join S&P MidCap 400 PR Newswire
05:13AM	ICON (NASDAQ:ICLR) Seems To Use Debt Rather Sparingly Simply Wall St.
Jun-17-21 09:25AM	ICON Announces Pricing of Senior Secured Notes Business Wire
Jun-15-21 04:15PM	ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting Business Wire
Jun-14-21 07:59AM	ICON Announces Private Offering of Senior Secured Notes Business Wire
May-28-21 04:08AM	Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR) Simply Wall St.
May-25-21 06:00AM	ICON plc to Present at the Jefferies Virtual Healthcare Conference and the William Blair 41st Growth Stock Conference Business Wire
May-05-21 06:30AM	ICON plc to Present at the BofA Securities 2021 Virtual Healthcare Conference and the UBS Virtual Global Healthcare Conference Business Wire
Apr-30-21 06:31PM	Icon PLC (ICLR) Q1 2021 Earnings Call Transcript Motley Fool
01:41PM	Baron Funds on ICON Public Ltd Co. (ICLR): We See Significant Upside in the Stock Price Insider Monkey
Apr-28-21 05:55PM	Icon PLC (ICLR) Q1 Earnings and Revenues Top Estimates Zacks
04:05PM	ICON Reports First Quarter 2021 Results Business Wire
03:47AM	Investors Who Bought ICON (NASDAQ:ICLR) Shares Five Years Ago Are Now Up 232% Simply Wall St.
Apr-20-21 04:35AM	ICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row Business Wire
Apr-16-21 06:58AM	Icon PLC (ICLR) Soars 4.5%: Is Further Upside Left in the Stock? Zacks
Apr-14-21 01:04PM	ICON Plc -- Moody's announces completion of a periodic review of ratings of ICON Plc Moody's
12:37PM	Is ICLR Stock A Buy or Sell? Insider Monkey
Mar-15-21 02:49AM	Is Weakness In ICON Public Limited Company (NASDAQ:ICLR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? Simply Wall St.
Mar-09-21 10:00AM	ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum Business Wire
Mar-08-21 06:44AM	Icon PLC (ICLR) Surges 4.6%: Is This an Indication of Further Gains? Zacks
Mar-01-21 11:02PM	Lifshitz Law Firm, P.C. Announces Investigation of APEX, CTB, GT, FRTA, PAND, PRAH, ICLR, PBCT and MBT PR Newswire
Feb-26-21 03:26PM	Pharmaceutical Research Associates, Inc. -- Moody's places PRA Holdings' ratings under review for upgrade on proposed acquisition by ICON Plc Moody's
01:33PM	ICON Plc -- Moody's places ICON's rating under review for downgrade Moody's
Feb-25-21 02:30PM	Icon PLC (ICLR) Q4 2020 Earnings Call Transcript Motley Fool
07:19AM	PRA Health Sciences To Be Acquired By ICON For $12B; Shares Pop 19% SmarterAnalyst
Feb-24-21 02:44PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates PRA Health Sciences Inc. PR Newswire -7.77%
01:42PM	Why PRA Health Sciences Stock Is Soaring Today Motley Fool
12:09PM	PRA HEALTH SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRAH and Encourages Investors to Contact the Firm GlobeNewswire
11:20AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PRA Health Sciences, Inc. Buyout GlobeNewswire
10:43AM	(PRAH): Johnson Fistel Investigates the Proposed Sale of PRA Health; Are Shareholders Getting a Fair Deal? PR Newswire
07:13AM	ICON Scoops Up PRA Health Sciences In $12B Deal Benzinga
06:12AM	Icon agrees to acquire PRA Health Sciences in cash and stock deal valued at about $12 billion MarketWatch
06:01AM	ICON Reports Fourth Quarter and Full Year 2020 Results Business Wire
06:00AM	ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research Business Wire
Feb-23-21 10:16AM	Earnings Preview: Icon Benzinga
Feb-16-21 07:30AM	Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial of CYTO-205 for the Treatment of COVID-19 PR Newswire
Feb-13-21 03:45AM	Is It Time To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)? Simply Wall St.
Feb-10-21 12:31PM	Icon PLC (ICLR) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release Zacks
Feb-08-21 04:30AM	ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support Business Wire
Feb-04-21 12:10PM	Will Icon PLC (ICLR) Beat Estimates Again in Its Next Earnings Report? Zacks
Jan-14-21 01:17AM	Is ICON (NASDAQ:ICLR) Using Too Much Debt? Simply Wall St.
Jan-07-21 04:15PM	ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference Business Wire
Jan-04-21 04:15AM	ICON Supports Pfizer and BioNTech on the Investigational COVID-19 Vaccine Trial Business Wire
Dec-15-20 01:22AM	Estimating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR) Simply Wall St.
Nov-11-20 06:00AM	ICON Releases First Environmental, Social and Governance Report Business Wire
Oct-30-20 07:00AM	ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference Business Wire
Oct-24-20 09:42AM	ICON Public Limited Company Just Recorded A 8.3% EPS Beat: Here's What Analysts Are Forecasting Next Simply Wall St.
Oct-22-20 08:01PM	Icon PLC (ICLR) Q3 2020 Earnings Call Transcript Motley Fool
Oct-21-20 05:35PM	Icon PLC (ICLR) Tops Q3 Earnings and Revenue Estimates Zacks
04:51PM	Recap: Icon Q3 Earnings Benzinga
04:15PM	ICON Reports Third Quarter 2020 Results Business Wire
Oct-19-20 09:00AM	BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response Business Wire
Oct-07-20 05:00AM	ICON Wins Best CRO at the Vaccine Industry Excellence Awards Business Wire
Sep-29-20 08:56AM	Hedge Funds Are Buying ICON Public Limited Company (ICLR) Insider Monkey
Sep-25-20 11:07AM	ICON Public Limited Company (NASDAQ:ICLR) Investors Are Less Pessimistic Than Expected Simply Wall St.
Sep-03-20 04:30AM	ICON Launches Accellacare a Global Clinical Research Network Focused on Increasing Patient Recruitment With a Patient Centric Approach Business Wire
Sep-02-20 07:00AM	ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference Business Wire
Aug-26-20 12:50PM	ICON Public Limited Company's (NASDAQ:ICLR) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St.
Aug-21-20 04:30AM	Forbes names ICON in list of Best Employers in America for Women Business Wire
Jul-30-20 01:30PM	ICON Plc -- Moody's affirms Baa3 issuer rating of ICON Plc, stable outlook Moody's
Jul-27-20 08:29PM	ICON Public Limited Company (ICLR): Were Hedge Funds Right About This Stock? Insider Monkey
11:16AM	These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Safely Simply Wall St.
Jul-23-20 09:01PM	Icon PLC (ICLR) Q2 2020 Earnings Call Transcript Motley Fool
Jul-22-20 07:35PM	Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates Zacks
04:59PM	Icon: Q2 Earnings Insights Benzinga
04:20PM	ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting Business Wire
04:15PM	ICON Reports Second Quarter 2020 Results Business Wire
Jun-18-20 03:33PM	Hedge Funds Parking Their Capital In ICON Public Limited Company (ICLR) Insider Monkey
Jun-11-20 08:05AM	Edited Transcript of ICLR earnings conference call or presentation 23-Apr-20 1:00pm GMT Thomson Reuters StreetEvents -5.99%
May-27-20 06:00AM	ICON plc to Present at Jefferies Virtual Healthcare Conference Business Wire
May-26-20 11:40AM	ICON Plc -- Moody's announces completion of a periodic review of ratings of ICON Plc Moody's
May-21-20 11:46AM	Quality Characteristics and Competition GuruFocus.com
May-13-20 06:00AM	ICON plc to Present at UBS Virtual Global Healthcare Conference Business Wire
May-05-20 04:30AM	ICON Appoints New Chief Medical Officer Business Wire

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience